Biondo Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Buy
52,266
+531
+1% +$341K 3.77% 6
2025
Q4
$35M Sell
51,735
-534
-1% -$364K 4.23% 6
2025
Q3
$33.4M Sell
52,269
-718
-1% -$436K 4.18% 6
2025
Q2
$28.4M Sell
52,987
-842
-2% -$403K 3.75% 6
2025
Q1
$22.6M Buy
53,829
+11,072
+26% +$4.81M 3.21% 7
2024
Q4
$17.7M Buy
42,757
+85
+0.2% +$37.3K 2.44% 9
2024
Q3
$21.6M Sell
42,672
-70
-0.2% -$34K 2.96% 7
2024
Q2
$20.8M Sell
42,742
-257
-0.6% -$129K 3.08% 8
2024
Q1
$23.2M Buy
42,999
+550
+1% +$301K 3.59% 6
2023
Q4
$23.6M Sell
42,449
-1,419
-3% -$666K 4% 6
2023
Q3
$19.2M Sell
43,868
-168
-0.4% -$83.8K 3.61% 6
2023
Q2
$22.1M Sell
44,036
-475
-1% -$228K 4.09% 6
2023
Q1
$22.3M Sell
44,511
-382
-0.9% -$183K 4.5% 4
2022
Q4
$18.3M Sell
44,893
-2,431
-5% -$944K 4.08% 4
2022
Q3
$15.4M Buy
47,324
+2,452
+5% +$901K 3.56% 6
2022
Q2
$15.7M Buy
44,872
+3,782
+9% +$1.54M 3.47% 6
2022
Q1
$22.5M Sell
41,090
-2,549
-6% -$1.34M 3.96% 6
2021
Q4
$28.7M Sell
43,639
-3,207
-7% -$2.01M 4.79% 3
2021
Q3
$29.1M Buy
46,846
+480
+1% +$323K 5% 3
2021
Q2
$29.3M Sell
46,366
-430
-0.9% -$237K 5.03% 3
2021
Q1
$22.9M Sell
46,796
-4,677
-9% -$2.34M 4.56% 6
2020
Q4
$25.7M Sell
51,473
-215
-0.4% -$96.2K 4.93% 6
2020
Q3
$20.3M Buy
51,688
+1,137
+2% +$420K 4.41% 6
2020
Q2
$16.7M Sell
50,551
-3,600
-7% -$1.04M 4.21% 7
2020
Q1
$13.1M Sell
54,151
-2,765
-5% -$722K 4.35% 6
2019
Q4
$14.9M Sell
56,916
-637
-1% -$168K 3.43% 7
2019
Q3
$15.7M Sell
57,553
-68
-0.1% -$18.9K 4% 6
2019
Q2
$15.9M Sell
57,621
-2,420
-4% -$596K 3.76% 7
2019
Q1
$13.4M Sell
60,041
-4,445
-7% -$918K 3.37% 9
2018
Q4
$12M Sell
64,486
-220
-0.3% -$45.1K 3.62% 7
2018
Q3
$16.2M Sell
64,706
-1,090
-2% -$265K 3.84% 6
2018
Q2
$14.3M Sell
65,796
-975
-1% -$201K 3.62% 5
2018
Q1
$12.8M Sell
66,771
-8,641
-11% -$1.59M 3.33% 5
2017
Q4
$11.8M Sell
75,412
-1,950
-3% -$307K 2.98% 9
2017
Q3
$12M Sell
77,362
-4,199
-5% -$664K 3.31% 6
2017
Q2
$13.2M Sell
81,561
-1,130
-1% -$184K 3.81% 8
2017
Q1
$7.68M Buy
82,691
+945
+1% +$130K 2.74% 10
2016
Q4
$9.59M Buy
81,746
+1,125
+1% +$128K 3.17% 9
2016
Q3
$9.09M Sell
80,621
-2,070
-3% -$218K 3.07% 7
2016
Q2
$7.68M Sell
82,691
-1,110
-1% -$95.3K 2.74% 10
2016
Q1
$6.56M Sell
83,801
-468
-0.6% -$33.7K 2.49% 11
2015
Q4
$6.14M Sell
84,269
-575
-0.7% -$41K 2.04% 14
2015
Q3
$6.3M Sell
84,844
-2,912
-3% -$209K 2.09% 15
2015
Q2
$5.63M Sell
87,756
-35,364
-29% -$2.45M 1.69% 16
2015
Q1
$9.51M Sell
123,120
-1,350
-1% -$105K 2.82% 11
2014
Q4
$9.23M Sell
124,470
-1,750
-1% -$123K 2.78% 12
2014
Q3
$7.44M Sell
126,220
-3,750
-3% -$237K 2.28% 13
2014
Q2
$8.68M Sell
129,970
-2,550
-2% -$162K 2.74% 12
2014
Q1
$8.04M Sell
132,520
-11,050
-8% -$658K 2.67% 12
2013
Q4
$7.64M Sell
143,570
-7,940
-5% -$418K 2.61% 12
2013
Q3
$7.55M Sell
151,510
-12,980
-8% -$624K 2.86% 11
2013
Q2
$7.38M Buy
+164,490
New +$7.19M 3.2% 9

Other funds holding IDXX

Biondo Investment Advisors's IDXX Position: Q1 2026 in Review

Biondo Investment Advisors increased its Idexx Laboratories (IDXX) stake by 1% in Q1 2026, buying an estimated $341K and bringing the position to 52,266 shares worth $29.4M. The position accounts for 3.77% of the portfolio, ranked #6.

Biondo Investment Advisors first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $35M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Biondo Investment Advisors held 52,266 shares of Idexx Laboratories worth $29.4M as of Q1 2026.
  • Biondo Investment Advisors bought 531 Idexx Laboratories shares in Q1 2026, an estimated $341K.
  • Idexx Laboratories made up 3.77% of Biondo Investment Advisors's portfolio in Q1 2026, its #6 holding.
  • Biondo Investment Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Biondo Investment Advisors's Idexx Laboratories position peaked at $35M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Biondo Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.